Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Acro Biomedical Co., Ltd. ACBM

Full chart Compare
Set alert

Price alert · ACBM

All alert types
0.03 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

0.026 Day range 0.026
0.0007 52-week range 0.10
YTD
+17.12%
1 year
+3,614.29%

Financial health

Altman Z-Score

-12930.52 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -13.1×
FY 2015: -4322×FY 2016: -81631×FY 2017: 442×FY 2019: -499×FY 2020: -1556×FY 2021: -33.2×FY 2022: -17.3×FY 2023: -0.7×FY 2024: -1.4×FY 2025: -13.1×
FY 2015 5y median -13.1× FY 2025
P/S 0.0×
FY 2015: 0.0×FY 2016: 360×FY 2017: 23.1×FY 2019: 960×FY 2020: 270×FY 2021: 209×FY 2022: 410×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025
P/B -3.4×
FY 2015: -12401×FY 2016: 359×FY 2017: 149×FY 2019: 233×FY 2020: 271×FY 2021: 389×FY 2022: 556×FY 2023: -24.5×FY 2024: -0.2×FY 2025: -3.4×
FY 2015 5y median -0.2× FY 2025
P/FCF -6.8×
FY 2015: -5280×FY 2016: -396×FY 2017: -1320×FY 2019: -3112×FY 2020: -931×FY 2021: 836×FY 2022: -1832×FY 2023: -408×FY 2024: -1.6×FY 2025: -6.8×
FY 2015 5y median -6.8× FY 2025
EV/EBITDA -10.7×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 360×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -17.0×FY 2023: 0.0×FY 2024: -2.3×FY 2025: -10.7×
FY 2015 5y median -2.3× FY 2025
EV/Sales 0.0×
FY 2015: 0.0×FY 2016: 360×FY 2017: 23.2×FY 2019: 960×FY 2020: 270×FY 2021: 209×FY 2022: 410×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025
FCF Yield -14.7%
FY 2015: -0.0%FY 2016: -0.3%FY 2017: -0.1%FY 2019: -0.0%FY 2020: -0.1%FY 2021: 0.1%FY 2022: -0.1%FY 2023: -0.2%FY 2024: -61.1%FY 2025: -14.7%
FY 2015 5y median -0.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2015: 0.0%FY 2016: 10.0%FY 2017: 10.4%FY 2019: 6.3%FY 2020: 23.2%FY 2021: 21.7%FY 2022: 21.3%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2015: 0.0%FY 2016: -0.4%FY 2017: 6.4%FY 2019: -218.4%FY 2020: -19.0%FY 2021: -642.5%FY 2022: -2410.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2015: 0.0%FY 2016: -0.4%FY 2017: 5.2%FY 2019: -192.0%FY 2020: -17.1%FY 2021: -643.2%FY 2022: -2410.2%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
ROE 26.1%
FY 2015: 293.6%FY 2016: -0.4%FY 2017: 33.8%FY 2019: -46.6%FY 2020: -17.1%FY 2021: -1196.5%FY 2022: -3263.2%FY 2023: 3426.9%FY 2024: 14.3%FY 2025: 26.1%
FY 2015 5y median 14.3% FY 2025
ROIC 250.6%
FY 2015: 906.1%FY 2016: -0.4%FY 2017: 30.6%FY 2019: -42.5%FY 2020: -11.9%FY 2021: -1108.4%FY 2022: -3099.0%FY 2023: 4299.4%FY 2024: 15.7%FY 2025: 250.6%
FY 2015 5y median 15.7% FY 2025
ROA -717.4%
FY 2015: -1714.5%FY 2016: -0.4%FY 2017: 28.3%FY 2019: -39.9%FY 2020: -11.8%FY 2021: -1012.0%FY 2022: -2308.6%FY 2023: -15066.2%FY 2024: -132.3%FY 2025: -717.4%
FY 2015 5y median -1012.0% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 1471.5%FY 2019: 0.0%FY 2020: 255.5%FY 2021: 74.1%FY 2022: -45.0%FY 2023: -100.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 FY 2025
Operating Income -305.8%
FY 2015: 8.6%FY 2016: 94.8%FY 2017: 23033.7%FY 2019: 0.0%FY 2020: 69.1%FY 2021: -5797.1%FY 2022: -106.3%FY 2023: 44.5%FY 2024: 99.6%FY 2025: -305.8%
FY 2015 FY 2025
EPS (diluted) -142.9%
FY 2015: 10.0%FY 2016: 94.7%FY 2017: 18566.6%FY 2019: 0.0%FY 2020: 67.9%FY 2021: -5500.0%FY 2022: -85.7%FY 2023: 42.3%FY 2024: 99.5%FY 2025: -142.9%
FY 2015 FY 2025
Free Cash Flow -435.0%
FY 2015: 28.9%FY 2016: -1233.7%FY 2017: 69.7%FY 2019: 0.0%FY 2020: -234.1%FY 2021: 250.1%FY 2022: -149.3%FY 2023: 89.5%FY 2024: -137.6%FY 2025: -435.0%
FY 2015 FY 2025

Financial Health

Current Ratio 0.0×
FY 2015: 0.1×FY 2016: 14.8×FY 2017: 6.1×FY 2019: 7.9×FY 2020: 3.1×FY 2021: 7.7×FY 2022: 3.3×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025
Quick Ratio 0.0×
FY 2015: 0.1×FY 2016: 1.8×FY 2017: 1.4×FY 2019: 7.9×FY 2020: 3.1×FY 2021: 7.6×FY 2022: 3.2×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025
Debt / Equity -0.8×
FY 2015: -0.7×FY 2016: 0.1×FY 2017: 0.1×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.1×FY 2023: -0.2×FY 2024: -0.1×FY 2025: -0.8×
FY 2015 5y median -0.1× FY 2025
Net Debt / EBITDA -2.1×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.3×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -0.0×FY 2023: 0.0×FY 2024: -0.7×FY 2025: -2.1×
FY 2015 5y median -0.0× FY 2025
Interest Coverage -16.8×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 141×FY 2019: -213×FY 2020: -25.7×FY 2021: -1810×FY 2022: -9302×FY 2023: -2746×FY 2024: -8.7×FY 2025: -16.8×
FY 2015 5y median -1810× FY 2025

Dividends

Dividend Yield 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31